FRANCHESCA SANCHEZ: Open Payments
NPI 1073271136 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,486 in 31 payments from 13 companies in 2025. Trend: 2023 $446 · 2024 $983 · 2025 $1,486
Food & beverage: $1,457Education: $29
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 8 | $574 |
| Otsuka America Pharmaceutical, Inc. | 4 | $256 |
| Xeris Pharmaceuticals, Inc. | 4 | $221 |
| Novo Nordisk Inc | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $48 |
| Dexcom, Inc. | 2 | $43 |
| Lundbeck LLC | 2 | $42 |
| Exact Sciences Corporation | 1 | $35 |
| ABBVIE INC. | 1 | $26 |
Products named: REXULTI, REPATHA, OTEZLA, RECORLEV, Wegovy, FARXIGA, Kerendia, Dexcom G6 Transmitter.
Industry payments across NY — which companies pay providers there.
